Wormser Freres Gestion Sells 20,682 Shares of Align Technology, Inc. $ALGN

Wormser Freres Gestion reduced its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN) by 85.2% in the second quarter, Holdings Channel.com reports. The fund owned 3,588 shares of the medical equipment provider’s stock after selling 20,682 shares during the quarter. Align Technology comprises about 0.4% of Wormser Freres Gestion’s portfolio, making the stock its 26th largest holding. Wormser Freres Gestion’s holdings in Align Technology were worth $679,000 as of its most recent filing with the SEC.

Several other large investors also recently added to or reduced their stakes in ALGN. Teacher Retirement System of Texas bought a new position in shares of Align Technology during the 1st quarter worth $1,647,000. Asset Management One Co. Ltd. boosted its holdings in Align Technology by 14.5% in the first quarter. Asset Management One Co. Ltd. now owns 31,624 shares of the medical equipment provider’s stock worth $5,024,000 after acquiring an additional 4,009 shares in the last quarter. Czech National Bank grew its position in Align Technology by 3.3% during the 2nd quarter. Czech National Bank now owns 16,654 shares of the medical equipment provider’s stock worth $3,153,000 after purchasing an additional 537 shares during the last quarter. Acadian Asset Management LLC acquired a new position in shares of Align Technology in the 1st quarter valued at $20,194,000. Finally, Parallel Advisors LLC raised its stake in shares of Align Technology by 66.0% in the second quarter. Parallel Advisors LLC now owns 1,044 shares of the medical equipment provider’s stock worth $198,000 after purchasing an additional 415 shares during the last quarter. 88.43% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Align Technology

In related news, CEO Joseph M. Hogan bought 7,576 shares of the stock in a transaction on Friday, August 1st. The stock was bought at an average price of $131.49 per share, with a total value of $996,168.24. Following the completion of the purchase, the chief executive officer directly owned 184,945 shares in the company, valued at $24,318,418.05. This represents a 4.27% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.66% of the company’s stock.

Align Technology Trading Up 2.7%

ALGN stock opened at $132.17 on Monday. The firm has a 50-day moving average of $140.20 and a two-hundred day moving average of $165.69. Align Technology, Inc. has a 12 month low of $122.00 and a 12 month high of $246.19. The company has a market cap of $9.58 billion, a price-to-earnings ratio of 22.29, a PEG ratio of 1.49 and a beta of 1.70.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.57 by ($0.08). The company had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $1.06 billion. Align Technology had a net margin of 11.04% and a return on equity of 13.36%. Align Technology’s revenue for the quarter was down 1.6% on a year-over-year basis. During the same quarter last year, the company earned $2.41 earnings per share. Align Technology has set its Q3 2025 guidance at EPS. As a group, equities analysts forecast that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology announced that its Board of Directors has authorized a stock repurchase program on Tuesday, August 5th that allows the company to buyback $200.00 million in outstanding shares. This buyback authorization allows the medical equipment provider to purchase up to 2% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its shares are undervalued.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on ALGN. Mizuho set a $210.00 target price on shares of Align Technology in a research report on Thursday, July 31st. Wells Fargo & Company lowered their target price on Align Technology from $246.00 to $199.00 and set an “overweight” rating on the stock in a research note on Thursday, July 31st. Morgan Stanley reiterated an “equal weight” rating and set a $154.00 price target (down from $249.00) on shares of Align Technology in a research report on Thursday, July 31st. Weiss Ratings restated a “hold (c-)” rating on shares of Align Technology in a research report on Saturday, September 27th. Finally, Stifel Nicolaus decreased their target price on shares of Align Technology from $275.00 to $200.00 and set a “buy” rating for the company in a research note on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Align Technology currently has a consensus rating of “Moderate Buy” and a consensus target price of $215.00.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.